Search results for: 'biologics products'

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides insights across recent developments for intelligent drug discovery solutions, precision oncology and novel biologics. The TOE also comprises innovations across stem cell therapies and radiotherapies.The Life Science, Health & Wellness TOE will feature d...

Next-generation fermentation pathways for sustainable fuel production represent an evolving suite of biological and bio-electrochemical processes designed to convert diverse carbon sources, such as CO₂, biomass, waste gases, and organic residues, into liquid fuels. These approaches integrate advances in metabolic engineering, synthetic biology, and...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides actionable insights across new developments in oncology, immunology, autoimmune disorders, and precision medicine, highlighting next-generation biologics, bispecific antibodies, kinase inhibitors, molecular glues, and antibody engineering platforms. The...

19 Sep 2018  |  North America  |  Market Research

Global Biologics Contract Development and Manufacturing Organization (CDMO) Market, Forecast to 2022

Investments in Single Use/Disposable Technologies to Capitalize on Growth Opportunities in High-value Low-volume Biologics

Infographics

×

Key Issues Addressed

The global pharmaceutical industry is evolving with the rising need for novel therapies in the changing disease landscape. As a result of rising prevalence of chronic infectious diseases as well as growing cancer incidence, market needs are shifting from traditional small molecules to large molecules. This study presents an overview of the global b...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides actionable insights across new developments in prebiotics, immunology, oncology, cell and gene therapies, antibody therapies, and precision medicine approaches. The TOE also encompasses technology advances across the use of AI and ML in drug discovery a...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides insights across recent technology advances across cell & gene therapies, immunotherapies, intelligent drug discovery approaches, automated biomanufacturing and microbiome sciences. The TOE also encompasses recent developments in proteomics, drug deliver...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping drug discovery, diagnostics, and therapeutic delivery across oncology, infectious diseases, rare and autoimmune disorders, metabolic and age-related conditions, neurodegenerative and neuromu...

The global automotive industry experienced dynamic transformations in 2024, driven by rapid advancements in powertrain technologies and shifting production strategies. As the industry adapts to a growing demand for electric vehicles (EVs) and hybrid powertrains, major original equipment manufacturers (OEMs) are refining their model portfolios to ca...

Qualified respondents to this Frost & Sullivan survey were invited to participate in a telephone interview examining their laboratory s product purchasing process in 2023 and expectations for 2024. Frost & Sullivan has conducted similar studies among the same targeted respondents since 2012. The survey provides companies with actionable and trendin...